Skip to main content

Dermal Fat Grafts & AlloDerm (ADM) Wraps — Surgical Graft-Based Penile Girth Augmentation

Autologous dermal fat grafts and acellular dermal matrix (ADM) wraps (AlloDerm and porcine variants) are two distinct but related surgical graft-based approaches to penile girth enhancement. Both place tissue around the penile shaft to increase circumference, but they differ fundamentally in material source, integration biology, complication profile, and long-term durability. Graft-based techniques generally produce moderate girth gains (+1.1 to 3.1 cm circumference) but carry a notably higher complication rate than injectable approaches — skin necrosis, wound infection, or reoperation reported in ~ 53% of surgical-graft studies in a contemporary narrative review.[1][2]

For the broader male cosmetic-genital-surgery decision framework see the Male Cosmetic Genital Surgery atlas page. For the only FDA-cleared cosmetic device see Penuma & Himplant. For the bovine-pericardium + plasma-gel composite see the Hardrock Sandwich Technique.

Part I — Autologous Dermal Fat Grafts​

Concept and rationale​

Autologous dermal fat grafts harvest a composite strip of dermis + subcutaneous fat from a donor site (typically the gluteal crease, lower abdomen, or groin), de-epithelialize the skin surface, and wrap or place the graft around the penile shaft in the subcutaneous plane. The dermal component provides structural integrity and resistance to resorption, while the fat component provides volume. This addresses the major limitation of pure fat injection — unpredictable and often severe resorption (25–80%).[3][4][5]

Surgical technique​

  • Donor-site harvest — fusiform or rectangular strip of skin and subcutaneous fat excised from the gluteal crease, lower abdomen, or inguinal region. The epidermis is removed (de-epithelialization), leaving the dermis and attached fat intact.[3][6]
  • Penile preparation — penile degloving through a circumcoronal (subcoronal) or infrapubic incision, dissecting the plane between dartos fascia and Buck's fascia.
  • Graft placement — the dermal fat strip is wrapped circumferentially or placed as dorsal / lateral patches around the penile shaft. Dermal surface outward (toward the skin); fat surface inward (toward Buck's fascia). Secured with absorbable sutures.[3][7]
  • Modified tunneling technique (Xu 2016) — a specially designed tunneling instrument facilitates pericavernous thickening without full degloving, reducing trauma to the neo-urethra and neurovascular bundle. Specifically developed for post-hypospadias adults.[7]
  • Closure — penile skin re-draped over the graft and closed; compressive dressing applied.

Key studies​

StudynPopulation / contextGirth gainLength gainNotes
Xu 2016 Ann Plast Surg[3]23Dermal fat graft + SLD + suprapubic skin advancement+1.67 ± 0.46 cm flaccid (6 mo)+2.27 ± 0.54 cm flaccid"Inconspicuous" graft shrinkage on US/CT; no curvature; significant MGIS improvement
Xu 2016 Aesthet Plast Surg[7]15Modified tunneling, post-hypospadias adults+1.53 ± 0.23 cm flaccid (6 mo)+1.67 ± 0.24 cm flaccidNo erection deficits or fistulae; MGIS 31.73 → 40.20
Spyropoulos 2005[6]3 (graft subset)Free dermal-fat graft shaft coverage+2.3 cm at base, +2.6 cm subcoronally (p = 0.003 / p = 0.0012)—91% reported significant (20–53%) improvement in sexual self-esteem and function

Advantages​

  • Biocompatible — autologous tissue; no immunogenic rejection.
  • Dermal scaffold resists resorption — unlike pure fat injection.[3]
  • No allograft donor-site morbidity.
  • Natural feel as the graft integrates with native tissue.

Limitations​

  • Donor-site morbidity — separate incision for harvest with associated scarring, pain, and wound complications.
  • Longer operative time vs allograft or injectable approaches.
  • Variable fat survival — despite the dermal scaffold, partial fat resorption occurs. General fat-graft survival ranges 40–80% with resorption rates 25–80%, depending on technique, recipient-site vascularity, and graft processing.[4][5][8]
  • Irregular resorption can produce penile lumps, nodules, and asymmetric deformity. Leithauser 1995 documented poor cosmetic and functional results from irregular fat resorption — dead fat cells can persist for years analogous to pseudolipoma of Glisson's capsule.[9]
  • Potential negative impact on penile length — graft implantation may shorten the penis through fibrosis and contracture in some series.[2]

Part II — Autologous Fat Injection (Lipofilling) — Comparator Context​

Distinct from dermal fat grafts but the most commonly performed fat-based girth procedure; included here for direct comparison.

  • Kang 2012 (n = 52) — fat injection into the superficial, middle, and deep layers of Colles' fascia. Mean injected volume 38.54 mL. At 6 months, circumference 7.01 → 9.29 cm proximally and 7.06 → 9.34 cm distally (both p < 0.001).[10]
  • Deskoulidi & Caminer 2023 (n = 75; 15-year experience) — fat injection combined with SLD and V-Y plasty. Circumference increase ~ +1 cm with "excellent natural results"; only 4% required fat-injection revision at 6–12 months.[11]
  • Major limitation — fat resorption is the Achilles heel. Resorption rates of 25–80% are reported, and the penile shaft (with its biomechanical environment of repeated erection / detumescence cycles) may be a particularly challenging recipient site for fat-graft survival.[4][5][8]

Part III — Acellular Dermal Matrix (ADM) Wraps — AlloDerm and Alternatives​

Concept and rationale​

ADM is processed human or animal dermis from which all cellular components have been removed, leaving an intact extracellular-matrix scaffold of collagen, elastin, and basement membrane. The scaffold serves as a template for host-tissue ingrowth and remodeling. The key advantage over autologous dermal fat grafts is the elimination of donor-site morbidity and shorter operative time.[12][13]

Available ADM products​

Three major allograft (human-derived) ADM products have been compared in penile augmentation.[13]

  • AlloDerm (LifeCell / Allergan) — freeze-dried human cadaveric dermis; the most widely recognized brand.
  • Belladerm (MTF Biologics) — aseptically processed human dermis.
  • Repriza (LifeNet Health) — gamma-irradiated human dermis.

In addition, xenograft (animal-derived) ADM products have been used.

  • Porcine dermal acellular grafts — processed porcine dermis.[12]

Surgical technique​

  • Penile degloving through a circumcoronal or penopubic incision; subcutaneous plane between dartos and Buck's fascia.[12][13]
  • Graft preparation — ADM sheet rehydrated (if lyophilized), trimmed to dimensions, and shaped to wrap circumferentially around the penile shaft.
  • Graft placement — at the level of Buck's fascia circumferentially around the shaft. Some techniques place the graft dorsolaterally only, leaving the ventral (urethral) surface ungrafted to avoid urethral compression.[12][13]
  • Fixation with absorbable sutures.
  • Closure — penile skin re-draped and closed; compressive dressing.
  • Alei penopubic-incision technique — short transverse incision at the penile base along the penopubic junction through which the ADM is inserted and advanced distally; conceals the scar in a crease covered by pubic hair.[12]

Key studies — ADM wraps​

StudynMaterialGirth gain (flaccid)Girth gain (erect)ComplicationsNotes
Alei 2012[12]69Porcine dermal ADM+3.1 cm (8.1 → 11.3 cm)+2.4 cm (10.8 → 13.2 cm)No major; minor resolved within 3 wkBeneficial psychosexual impact; sexual activity at 1–2 mo
Solomon 2013[13]47 (AlloDerm 9 / Belladerm 20 / Repriza 21)Human allograft ADMNot reportedNot reported42% infection / graft exposure; 36% exposure; 6% total graft lossNo significant difference between brands (p > 0.05)
Xu 2019[14]78ADM (type not specified)+1.1 cm (range 0.5–2.1)Not reported60.3% erectile discomfort; 15.4% delayed healing; 12.8% unobvious effect; 10.3% hematoma; 9.0% prepuce edema; 5.1% infection; 3.8% skin necrosis; 9% required ADM removalAuthors concluded ADM "is not an ideal or safe method for PGE"

Critical analysis of ADM outcomes​

The ADM literature reveals a striking discrepancy between Alei's favorable single-center series and the concerning complication profiles reported by Solomon and Xu.

  • Alei 2012 (most favorable) — porcine dermal ADM via penopubic incision; largest girth gains in the ADM literature (+3.1 cm flaccid, +2.4 cm erect at 1 yr); no major complications. Authors concluded ADM has "several advantages over autogenous dermis-fat grafts: the elimination of donor-site morbidity and a significantly shorter operation time."[12]
  • Solomon 2013 (only comparative allograft study) — circumferential AlloDerm / Belladerm / Repriza at Buck's-fascia level; 42% infection / open-wound graft exposure; 6% total graft loss; no significant difference between brands. No AlloDerm patient had total graft loss (0/9), but the sample was too small for meaningful comparison.[13]
  • Xu 2019 (largest ADM-complication series) — 60.3% erectile discomfort described as tightness or constriction during erection; 9% required ADM removal. Authors' verdict: even with standardized methods and rigorous postoperative care, complications of penile girth enhancement using ADM are severe — not an ideal or safe method.[14]

Part IV — ADM as Infrapubic Space Filler (Combined With SLD)​

A distinct application of ADM is as a space filler in the infrapubic dead space after suspensory-ligament release rather than as a circumferential girth wrap.

  • Zhang 2019 (n = 15) — SLD + suprapubic liposuction + folded ADM placed between the corpora cavernosa and pubic symphysis. Penile length increased by +2.4 cm at 3 months (3.0 → 5.4 cm). Complications included edema, ecchymosis, and poor wound healing. 100% patient satisfaction with appearance and function. The ADM in this application serves to prevent penile retraction after SLD rather than to enhance girth.[15]

Part V — Comparator Techniques​

Tissue-engineered biodegradable scaffolds (PLGA + autologous fibroblasts)​

The most scientifically rigorous graft-based approach is the Perovic / Djordjevic tissue-engineering technique — a fundamentally different paradigm from passive graft placement. PLGA (poly-lactic-co-glycolic acid) biodegradable scaffolds seeded with autologous fibroblasts degrade over months while the seeded cells generate new autologous tissue (neotissue) that permanently replaces the scaffold.[16][17][18]

  • Perovic 2006 (n = 204 multicenter prospective) — foundational study; 84-pt subset with 1–5-yr follow-up (median 24 mo); girth gain 1.9–4.1 cm (mean 3.15 cm); complications infection 1.5%, skin pressure necrosis 1%, seroma 2.5% (all conservative); satisfaction mean 4.25/5.[16]
  • Perovic & Djordjevic 2010 (n = 12 histomorphometric) — biopsies at 10–14 mo showed highly vascularized loose tissue with collagen deposition, fibroblast-like hyperplasia, and neoangiogenesis; at 22–24 mo inflammation almost disappeared and the tissue closely resembled native dartos fascia. Girth +2.1 ± 0.28 cm flaccid, +1.9 ± 0.28 cm erect; satisfaction 75% "very good" / 25% "good."[17]
  • Djordjevic 2018 (n = 21 repeated procedure) — second PLGA enhancement after a first procedure; additional girth +1.1 ± 0.4 cm flaccid / +1.0 ± 0.3 cm erect (statistically significant); ultrastructural analysis confirmed abundant collagen fibrils with scattered fibroblasts — stable neotissue formation.[18]

Saphenous vein grafts (albugineal surgery)​

Fundamentally different: intracorporeal grafting placing saphenous vein into longitudinal incisions in the tunica albuginea to expand the corpora cavernosa themselves, producing girth enhancement during erection (not flaccid state).

  • Austoni 2002 (n = 39) — bilateral longitudinal albugineal incisions with saphenous-vein grafts. No flaccid-diameter change; erect diameter 2.9 → 4.2 cm (+1.1 to 2.1 cm, p < 0.001).[19]
  • Yang 2009 (n = 20) — saphenous-vein grafts vs ePTFE patches for albugineal augmentation; both achieved +1.0 to 3.0 cm erect circumference on table with some reduction (0.5–1 cm) at 12 mo to 5 yr. 17/20 married patients resumed satisfactory sexual activity at 1 month.[20]

This approach uniquely enhances functional (erect) girth by expanding the corpora rather than adding subcutaneous bulk. Theoretical risk of erectile dysfunction from tunical disruption; donor-site morbidity from saphenous-vein harvest.

Part VI — Comparative Summary​

TechniqueMaterialGirth gainDurabilityDonor-site morbidityComplication rateKey concern
Autologous dermal fat graftPatient's own dermis + fat+1.5–2.6 cmModerate (some fat resorption)Yes (gluteal / abdominal)Low in favorable seriesFat resorption; irregular nodules
Autologous fat injectionPatient's own fat+2.0–2.3 cmPoor (25–80% resorption)Minimal (liposuction)Low acutely; high long-term revisionUnpredictable resorption; nodules; deformity
AlloDerm / allograft ADM wrapHuman cadaveric dermis+1.1 cm (Xu 2019); not reported (Solomon)VariableNone42% infection / exposure (Solomon); 60% erectile discomfort (Xu)High complication rate; "not ideal or safe" per Xu
Porcine ADM wrap (Alei)Porcine dermis+3.1 cm flaccid / +2.4 cm erectGood (1-yr data)NoneLow (minor only)Single-center; not replicated
PLGA scaffold + fibroblastsBiodegradable scaffold + autologous cells+3.15 cm (mean)Permanent (neotissue)Minimal (scrotal biopsy)~ 4.8% (all conservative)Requires cell-culture lab; very limited availability
Saphenous vein (albugineal)Autologous vein+1.1–2.1 cm (erect only)GoodYes (leg incision)LowErect girth only; no flaccid change; ED risk
Hardrock Sandwich TechniqueBovine pericardium + autologous plasma gel+43.1% (+4.51 cm at POD 1)Likely permanentNone~ 12.7%Single-center retrospective; POD-1 measurement may overestimate
Penuma / HimplantSilicone elastomer (FDA 510(k))+56.7% (+4.9 cm)Permanent in situNone3–10% removal ratePermanent foreign body; single-surgeon foundational data

Part VII — Complications: Comprehensive Overview​

Graft-based penile augmentation carries the highest complication rate among penile-enhancement approaches. A narrative review found that skin necrosis, wound infection, or need for reoperation was reported in ~ 53% of surgical-graft studies — far higher than for injectable therapies.[1]

Wound-related.

  • Infection / graft exposure 5–42% depending on technique and material.[13][14]
  • Skin necrosis 1–4%, particularly dorsally where the graft may compress skin against the underlying shaft.[14][16]
  • Delayed healing 15%.[14]
  • Hematoma 10%.[14]

Graft-related.

  • Erectile discomfort / constriction up to ~ 60% with ADM wraps — the graft may restrict penile expansion during erection.[14]
  • Unobvious augmentation effect 13% — insufficient girth gain.[14]
  • Graft resorption / contraction — variable; dermal fat grafts show "inconspicuous" shrinkage in favorable series and unpredictable resorption in others.[3][9]
  • Graft removal required 9% with ADM.[14]
  • Negative impact on penile length — graft implantation may paradoxically shorten the penis through fibrosis and contracture.[2]

Severe / referral-center complications.

  • Furr 2018 referral series — sexually disabling penile deformity, severe shortening, curvature, edema, subcutaneous masses, infection, non-healing wounds, and sexual dysfunction in patients presenting after various genital-enlargement surgeries; 10/11 required corrective surgery, 3 with split-thickness skin grafting.[22]
  • Wessells 1996 — 12 men presenting after augmentation (SLD + fat injection): chief complaints poor cosmetic appearance — irregular fat nodules 58%, skin deformity / scarring 33%, scrotalization 33%; reoperation in 50%; only 1 patient reported subjective length increase.[21]
  • Alter 1997 — 30+ patients presenting for reconstruction of deformities after penile-enlargement surgery, including disappearance of fat, penile lumps and nodules, shaft deformity, hypertrophic scarring, proximal penile humps, and low-hanging penis.[23]

Part VIII — Critical Appraisal and Position Statements​

  • Vardi 2008 — comprehensive critical analysis of penile-enhancement procedures concluded that "unwanted outcomes and complications, namely penile deformity, paradoxical penile shortening, disagreeable scarring, granuloma formation, migration of injected material, and sexual dysfunction were reported frequently." Patient-satisfaction rates were "disappointing" in most studies. Authors' verdict: these procedures should be regarded as investigational and patients should be discouraged from undergoing these invasive treatments.[24]
  • SMSNA 2024 position statement — all cosmetic penile-enhancement procedures, including graft-based techniques, are investigational with limited data. A multidisciplinary approach with mandatory psychological screening (BDDQ-AS / BDD-YBOCS) is required to identify patients with penile dysmorphic disorder.[25]
  • Manfredi 2022 narrative review — "good efficacy and satisfaction with a non-negligible risk of complications in patients undergoing surgical treatments," but adverse events are "probably largely under-reported" and these procedures "should still be considered under investigation."[1]

Key Clinical Considerations​

  • ADM wraps carry the highest complication rate among graft-based approaches. The Xu 2019 study (n = 78) concluded that ADM is "not an ideal or safe method" for penile girth enhancement. The 60% erectile-discomfort rate is particularly concerning.[14]
  • Porcine ADM (Alei technique) produced the best ADM outcomes (+3.1 cm flaccid girth, no major complications), but this is a single-center, non-replicated series and may reflect surgeon expertise rather than material superiority.[12]
  • PLGA tissue engineering (Perovic / Djordjevic) has the strongest scientific rationale and the best safety profile (~ 4.8% complication rate) among surgical graft approaches, with histological confirmation of stable neotissue formation. It requires a cell-culture laboratory, is available at very few centers worldwide, and involves a two-stage process (biopsy → weeks of cell culture → implantation).[16][17][18]
  • Autologous dermal fat grafts are a reasonable middle ground — lower complication rates than ADM wraps, no need for cell culture, and the dermal component provides structural resistance to resorption. Donor-site morbidity and variable fat survival remain limitations.[3][7]
  • Pure fat injection is the simplest and most widely performed technique but has the most unpredictable long-term results owing to fat resorption; the referral-center literature is dominated by complications from this approach.[9][21][23]
  • All graft-based approaches require penile degloving (except the Xu tunneling technique), which carries inherent risks of lymphatic disruption, edema, altered sensation, and skin compromise.

See Also​

References​

1. Manfredi C, Romero Otero J, Djinovic R. Penile girth-enhancement procedures for aesthetic purposes. Int J Impot Res. 2022;34(4):337–342. doi:10.1038/s41443-021-00459-y

2. Ramazan M, Øbro LF, Wiborg MH, et al. Complications of penile augmentation: a narrative review of injectables, implants, and surgical grafts. Int J Impot Res. 2026;38(3):238–246. doi:10.1038/s41443-025-01190-8

3. Xu L, Zhao M, Chen W, et al. Augmentation phalloplasty with autologous dermal fat graft in the treatment of "small penis." Ann Plast Surg. 2016;77(Suppl 1):S60–S65. doi:10.1097/SAP.0000000000000782

4. Limido E, Weinzierl A, Harder Y, Menger MD, Laschke MW. Fatter is better: boosting the vascularization of adipose-tissue grafts. Tissue Eng Part B Rev. 2023;29(6):605–622. doi:10.1089/ten.TEB.2023.0069

5. Kølle SF, Fischer-Nielsen A, Mathiasen AB, et al. Enrichment of autologous fat grafts with ex-vivo expanded adipose-tissue-derived stem cells for graft survival: a randomised placebo-controlled trial. Lancet. 2013;382(9898):1113–1120. doi:10.1016/S0140-6736(13)61410-5

6. Spyropoulos E, Christoforidis C, Borousas D, et al. Augmentation phalloplasty surgery for penile dysmorphophobia in young adults: considerations regarding patient selection, outcome evaluation and techniques applied. Eur Urol. 2005;48(1):121–127. doi:10.1016/j.eururo.2005.02.021

7. Xu L, Zhao M, Yang Z, et al. Modified penile augmentation by dermal-fat graft in post-hypospadias adults. Aesthet Plast Surg. 2016;40(1):120–129. doi:10.1007/s00266-015-0593-6

8. Tocco I, Widgerow AD, Lalezari S, et al. Lipotransfer: the potential from bench to bedside. Ann Plast Surg. 2014;72(5):599–609. doi:10.1097/SAP.0000000000000154

9. Leithauser LG, Gilbert E, Barton J. Complications of fat grafting to the penis. Ann Plast Surg. 1995;34(2):173–175. doi:10.1097/00000637-199502000-00010

10. Kang DH, Chung JH, Kim YJ, et al. Efficacy and safety of penile girth enhancement by autologous fat injection for patients with thin penises. Aesthet Plast Surg. 2012;36(4):813–818. doi:10.1007/s00266-012-9891-4

11. Deskoulidi PI, Caminer D. Lengthening phalloplasty with division of the suspensory ligament and distally based fat flaps in penis-enlargement operations. Plast Reconstr Surg. 2023;152(3):434e–437e. doi:10.1097/PRS.0000000000010313

12. Alei G, Letizia P, Ricottilli F, et al. Original technique for penile girth augmentation through porcine dermal acellular grafts: results in a 69-patient series. J Sex Med. 2012;9(7):1945–1953. doi:10.1111/j.1743-6109.2012.02744.x

13. Solomon MP, Komlo C, Defrain M. Allograft materials in phalloplasty: a comparative analysis. Ann Plast Surg. 2013;71(3):297–299. doi:10.1097/SAP.0b013e318281aece

14. Xu T, Zhang G, Bai W, et al. Complications and management of penile girth enhancement with acellular dermal matrix. J Sex Med. 2019;16(12):2011–2017. doi:10.1016/j.jsxm.2019.09.010

15. Zhang X, Huang Z, Xiao Y, et al. Suspensory ligament release combined with acellular dermal matrix filler in infrapubic space: a new method for penile length augmentation. Andrologia. 2019;51(9):e13351. doi:10.1111/and.13351

16. Perovic SV, Byun JS, Scheplev P, et al. New perspectives of penile enhancement surgery: tissue engineering with biodegradable scaffolds. Eur Urol. 2006;49(1):139–147. doi:10.1016/j.eururo.2005.08.016

17. Perovic SV, Sansalone S, Djinovic R, et al. Penile enhancement using autologous tissue engineering with biodegradable scaffold: a clinical and histomorphometric study. J Sex Med. 2010;7(9):3206–3215. doi:10.1111/j.1743-6109.2009.01545.x

18. Djordjevic ML, Bumbasirevic U, Stojanovic B, et al. Repeated penile girth enhancement with biodegradable scaffolds: microscopic ultrastructural analysis and surgical benefits. Asian J Androl. 2018;20(5):488–492. doi:10.4103/aja.aja_35_18

19. Austoni E, Guarneri A, Cazzaniga A. A new technique for augmentation phalloplasty: albugineal surgery with bilateral saphenous grafts — three years of experience. Eur Urol. 2002;42(3):245–253. doi:10.1016/s0302-2838(02)00264-6

20. Yang B, Liu XR, Hong QQ, Qiu RS, Ji CY. A comparative study on two kinds of surgical procedures of penile corpora cavernosa augmentation. J Plast Reconstr Aesthet Surg. 2009;62(3):357–364. doi:10.1016/j.bjps.2008.11.033

21. Wessells H, Lue TF, McAninch JW. Complications of penile lengthening and augmentation seen at one referral center. J Urol. 1996;155(5):1617–1620.

22. Furr J, Hebert K, Wisenbaugh E, Gelman J. Complications of genital-enlargement surgery. J Sex Med. 2018;15(12):1811–1817. doi:10.1016/j.jsxm.2018.10.007

23. Alter GJ. Reconstruction of deformities resulting from penile enlargement surgery. J Urol. 1997;158(6):2153–2157. doi:10.1016/s0022-5347(01)68185-0

24. Vardi Y, Har-Shai Y, Gil T, Gruenwald I. A critical analysis of penile-enhancement procedures for patients with normal penile size: surgical techniques, success, and complications. Eur Urol. 2008;54(5):1042–1050. doi:10.1016/j.eururo.2008.07.080

25. Trost L, Watter DN, Carrier S, et al. Cosmetic penile-enhancement procedures: an SMSNA position statement. J Sex Med. 2024;21(6):573–578. doi:10.1093/jsxmed/qdae045